埃索美拉唑联合胸腺蛋白口服液治疗消化性溃疡疗效观察

http://www.100md.com 2011年7月25日 张柏华

闁稿繑濞婇弫顓犳嫚瀹ュ繒绐� ,埃索美拉唑胸腺蛋白口服液消化性溃疡

第1页

    参见附件。

     【摘要】  目的探索埃索美拉唑联合胸腺蛋白口服液对消化腺溃疡的疗效。方法将102例患者随机分为治疗组与对照组,对照组服用埃索美拉唑,治疗组加用胸腺蛋白口服液,疗效均4周。结果2组治疗后总愈合率及总有效率均显著高于对照组(P<0.05)。结论与单纯服用埃索美拉唑相比,两者联合治疗疗效确切,复发率低,愈合质量提高。

    【关键词】 埃索美拉唑胸腺蛋白口服液消化性溃疡

    【中图分类号】 R573.1 【文献标识码】 A【文章编号】1674-0742(2011)07(c)-0018-02

    The Clinical Observation of the Medical Treatment for Peptic Ulcer with the Combination of Both Esomeprazole and Thymus Protein Oral Solution

    ZHANG Bohua

    Shangqiu Traditional Chinese Medicine Hospital,Henan Shangqiu 476000,China

    【Abstract】 Objective This research mainly explores the therapeutic effect of the Esomeprazole pills combined with Thymus Protein Oral Solution for Peptic Ulcer.Methods To achieve this goal,the writer randomly divides 102 cases into the experimental group and the control group.The control group only take the Esomeprazole pills,while the experimental group also take the Thymus Protein Oral Solution besides the Esomeprazole pills.ResultsThe medical treatment of both groups lasts 4 weeks ......

    http://www.100md.com/html/paper/1674-0742/2011/21/11.htm

您现在查看是摘要介绍页，详见PDF附件。